<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00465478</url>
  </required_header>
  <id_info>
    <org_study_id>QL060308</org_study_id>
    <nct_id>NCT00465478</nct_id>
  </id_info>
  <brief_title>Autologous Bone Marrow Mononuclear Cells Transplantation in Treating Diabetes Patients</brief_title>
  <official_title>Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Patients With Type 1 or 2 Diabetes Mellitus－a Phase 1/2 Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates the safety and efficiency of autologous bone marrow mononuclear cell
      transplantation in treating patients with type 1 or 2 Diabetes Mellitus. We hypothesize that
      autologous bone marrow stem cell transplantation will promote β-cells regeneration by
      directly differentiated from the transplanted BMMCs or stimulated local stem cells
      regeneration and thus decrease or eliminate the need of exogenous insulin and improve β-cells
      function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with type 1 or 2 Diabetes mellitus will be recruited according to eligibility
      criteria. Bone marrow mononuclear cells (BMMCs) will be separated from the bone marrow
      aspirate of each patient and be directly delivered to pancreas via splenic artery with the
      distal lumen occlusion through an arterial catheter. All patients will be explained in
      details about the procedures involved in BMMC transplantation and sign the informed consent
      for the study; The Ethics Committee of Qilu hospital, ShanDong university approved the
      treatment protocol. All patients undergo scheduled follow-up evaluations for 5 years after
      transplantation. Clinical, hematological, metabolical evaluations are performed to analyses
      the effect of the transplant, Patients fitting the inclusion criteria but not agreeing to
      perform the transplantation are the control group and will received the regular OHA and/or
      insulin therapy .They are followed in parallel with transplanted patients and will be
      subjected to the same follow-up management including extensive endocrinological monitoring,
      diet and exercise program as transplantation patients during the follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2006</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exogenous insulin requirement; Hemoglobin A1C; Glucose and C-peptide level;</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety assessment parameter: amylase, hepatic function,renal function,</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>lipid profile, autoantibody， Quality of life</measure>
  </secondary_outcome>
  <enrollment>200</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <condition>Diabetes Mellitus, Type 2</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Autologous bone marrow mononuclear cell transplantation</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 1 or type 2 diabetes

          -  Between 16 to 65 years of age

          -  Requiring daily exogenous insulin injection for the glycaemic control

          -  With poor β-cell function

          -  Body mass index (BMI) &lt; 28

        Exclusion Criteria:

          -  Acute or chronic infections

          -  Chronic uncompensated organic insufficiency including heart, liver, renal and lung

          -  Any malignancies, congenital or acquired immunodeficiency

          -  Hematological diseases or coagulopathy

          -  Acute or chronic pancreatitis

          -  History of thoracic or abdominal aorta diseases

          -  Allergy to iodine

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beihua Kong, MD PHD</last_name>
    <role>Study Director</role>
    <affiliation>Shandong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Li Chen, MD</last_name>
    <phone>0086-531-82169408</phone>
    <email>chenli3@medmail.com.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xingli Wang, MD PhD</last_name>
    <phone>832-355-9939</phone>
    <email>xlwang@bcm.tmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Qilu Hospital of Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li Chen, MD</last_name>
      <phone>0086-531-82169408</phone>
      <email>chenli3@medmai.com.cn</email>
    </contact>
    <contact_backup>
      <last_name>Xingli Wang, MD,PhD</last_name>
      <phone>832-355-9939</phone>
      <email>xlwang@bcm.tmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Li Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xingli Wang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Weikai Hou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jianjun Dong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kuanxiao Tang, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xinguo Hou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lei Sun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.qiluhospital.com</url>
  </link>
  <verification_date>April 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2007</study_first_submitted>
  <study_first_submitted_qc>April 24, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2007</study_first_posted>
  <last_update_submitted>April 24, 2007</last_update_submitted>
  <last_update_submitted_qc>April 24, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 25, 2007</last_update_posted>
  <keyword>Diabetes Mellitus</keyword>
  <keyword>Bone Marros Mononuclear Cells</keyword>
  <keyword>Transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

